Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhancing RECK Expression Through miR-21 Inhibition: A Promising Strategy for Bladder Carcinoma Control.
Dos Santos PRM, da Silva Gomes PR, Romão P, Maluf FC, Guimarães VR, Candido P, Gonçalves GL, de Camargo JA, Dos Santos GA, Silva I, Leite KRM, Nahas W, Reis ST, Pimenta R, Viana NI. Dos Santos PRM, et al. Among authors: de camargo ja. Biochem Genet. 2024 Mar 24. doi: 10.1007/s10528-024-10714-8. Online ahead of print. Biochem Genet. 2024. PMID: 38522065
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer.
Dos Santos GA, Viana NI, Pimenta R, de Camargo JA, Guimaraes VR, Romão P, Candido P, Dos Santos VG, Ghazarian V, Reis ST, Leite KRM, Srougi M. Dos Santos GA, et al. Among authors: de camargo ja. Cancer Genet. 2024 Jun;284-285:20-29. doi: 10.1016/j.cancergen.2024.03.006. Epub 2024 Mar 16. Cancer Genet. 2024. PMID: 38503134
Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R, Malulf FC, Romão P, Caetano GVB, da Silva KS, Ghazarian V, Dos Santos GA, Guimarães V, Silva IA, de Camargo JA, Recuero S, Melão BVLA, Antunes AA, Srougi M, Nahas W, Leite KRM, Reis ST. Pimenta R, et al. Among authors: de camargo ja. J Cancer Res Clin Oncol. 2024 Feb 2;150(2):70. doi: 10.1007/s00432-023-05598-x. J Cancer Res Clin Oncol. 2024. PMID: 38305916 Free PMC article.
Letter to the Editors regarding "10% body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis".
Berry SCL, Cohen SM, Corton JC, de Camargo JLV, Eisenbrand G, Fukushima S, Greim H, Weber K, Rietjens IMCM, Strupp C. Berry SCL, et al. Among authors: de camargo jlv. Regul Toxicol Pharmacol. 2023 Mar;139:105362. doi: 10.1016/j.yrtph.2023.105362. Epub 2023 Feb 22. Regul Toxicol Pharmacol. 2023. PMID: 36828242 No abstract available.
131 results